HRS-5817
Asset
Investigational therapy for obesity
- Stage
- Phase 1
- Modality
- Peptide
- Target
- Not known
- 2
- Indications
- 2
- Trials
- 2
- Developers
2 trials are still running. Trial NCT07238647 updated in its registry on May 12, 2026. clinicaltrials.gov
Indications
2Obesity
Phase 1, Recruiting, NCT06934408, clinicaltrials.gov, Oct 31, 2026
Overweight
Phase 1, Recruiting, NCT06934408, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Owner and partners2
- Trials2
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.